Alavert

   
Google
 
Web NewDrugInformation.com

Alavert


Drug - Alavert
The trade name of the product as shown on the labeling.

Dosage - TABLET, ORALLY DISINTEGRATING; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Loratadine
Multiple ingredients are in alphabetical order.

Strength - 10MG
The potency of the active ingredient(s), Loratadine. May repeat for multiple part products.

Applicant - WYETH CONS
The firm name holding legal responsibility for Alavert. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 021375
The FDA assigned number to Alavert. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Alavert. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Dec 19, 2002
The date Alavert was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Alavert. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - OTC
The group or category of approved drugs Alavert is in. Format is RX, OTC, DISCN.

Applicant Full Name - Wyeth Consumer Healthcare
The full name of the firm holding legal responsibility for the new application of Alavert.

Alavert